Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
In the early years of the highly active antiretroviral therapy (HAART) era, HIV with resistance to two or more agents in different antiretroviral classes posed a significant clinical challenge. Multidrug-resistant (MDR) HIV was an important cause of treatment failure, morbidity, and mortality. Treat...
Saved in:
| Main Authors: | Marianne Harris, Bohdan Nosyk, Richard Harrigan, Viviane Dias Lima, Calvin Cohen, Julio Montaner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | AIDS Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2012/595762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada.
by: Lillian Lourenço, et al.
Published: (2014-01-01) -
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.
by: Julio S G Montaner, et al.
Published: (2014-01-01) -
Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification.
by: Viviane D Lima, et al.
Published: (2017-01-01) -
Past, Present, and Future of Familial Hypercholesterolemia Management
by: Viviane Z. Rocha, et al.
Published: (2021-09-01) -
COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)